Use of cyclic gmp-specific phosphodiesterase inhibitors for...

Details Use of cyclic gmp-specific phosphodiesterase inhibitors for... Use of cyclic gmp-specific phosphodiesterase inhibitors for...

A - Human Necessities

61

K

A61K 31/505 (2006.01) A61K 31/00 (2006.01) A61K 31/435 (2006.01) A61K 31/437 (2006.01) A61K 31/495 (2006.01) A61K 31/4985 (2006.01) A61K 31/519 (2006.01) A61P 25/16 (2006.01)

Patent

CA 2407031

The present invention relates generally to novel therapeutic methods for treating Parkinson's Disease by administering cyclic GMP-specific phosphodiesterase inhibitor compounds.

L'invention concerne généralement des méthodes de soins destinées au traitement de la maladie de Parkinson consistant à administrer des composés inhibiteurs de phosphodiestérase spécifique de GMP cyclique.

Affiliated with

Also associated with

Rating

Use of cyclic gmp-specific phosphodiesterase inhibitors for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cyclic gmp-specific phosphodiesterase inhibitors for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cyclic gmp-specific phosphodiesterase inhibitors for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1782789